What Recent Research Suggests About Migraine Progression

What is “migraine progression”?

Migraine progression refers to a pattern in which migraine becomes more frequent or more disabling over time, sometimes moving toward chronic migraine. Not everyone with migraine progresses, but understanding risk factors may help identify people who need closer follow-up and more thoughtful treatment planning.^[1]

A recent review looked at what may increase risk

A 2023 narrative review in the Journal of Neurology summarized evidence on factors associated with migraine disease progression. The authors grouped these factors into several major categories, including headache-related features, treatment patterns, comorbid conditions, lifestyle factors, and demographic factors.^[1]

Key takeaways from the review

1. Higher baseline headache frequency matters. One of the most consistent findings in the review was that people who already have more frequent headaches appear to be at higher risk of progression over time. In other words, headache frequency itself may be both a burden and a warning sign.^[1]
2. Medication overuse is an important modifiable risk. The review identified acute medication overuse as one of the most consistently reported potentially modifiable risks. Overuse of certain short-term headache medicines may be associated with worsening headache patterns and chronicity.^[1]
3. Comorbid conditions may play a major role. Psychiatric conditions such as depression and anxiety, along with sleep problems, chronic pain conditions, and some metabolic or respiratory issues, were also associated with greater risk in the review. This supports the idea that migraine often needs to be treated in the context of the whole person, not just the headache itself.^[1]
4. Lifestyle factors may contribute. The review also discussed potentially relevant lifestyle or environmental factors, including poor sleep, physical inactivity, tobacco exposure, high caffeine intake, and financial or social barriers that may interfere with care.^[1]
5. Not all risk factors are equally changeable. Some factors may be modifiable, while others are not. The review emphasized that medication patterns, headache frequency, sleep, and certain comorbidities may be particularly important areas to pay attention to in clinical care.^[1]

What the review does not prove

This was a narrative review, not a systematic review or pooled meta-analysis. That means it is helpful for identifying clinically relevant patterns, but it does not prove that any one factor directly causes migraine progression. The authors also noted that evidence for specific prevention strategies remains limited and that more prospective interventional research is needed.^[1]

What this means for patients

For patients, the message is not that progression is inevitable. Rather, it suggests that it may be helpful to pay attention to:

• Increasing headache frequency
• Escalating use of acute medications
• Sleep and lifestyle patterns
• Mood symptoms such as depression or anxiety
• Whether treatment is actually working

These are often the kinds of issues worth reviewing during follow-up care.

Bottom line

This 2023 review supports a practical clinical idea: migraine progression appears to be multifactorial. Headache frequency, medication overuse, comorbid conditions, and lifestyle factors may all matter. Some of these risks may be modifiable, which makes careful follow-up and individualized treatment especially important.^[1]